Imihype C 250 Injection containing Imipenem and Cilastatin is used for the management of severe bacterial infections. It helps provide broad-spectrum antibacterial coverage and supports effective infection control in critical care settings.
Imipenem works as a carbapenem antibiotic that inhibits bacterial cell wall synthesis, while Cilastatin helps prevent the breakdown of Imipenem in the kidneys, enhancing its therapeutic effectiveness.
The injection is widely prescribed in hospital and intensive care settings for complicated respiratory, urinary tract, abdominal, skin, and systemic bacterial infections, leading to consistent institutional demand.
With increasing prevalence of resistant bacterial infections and growing demand for advanced critical care antibiotics, this product offers strong business potential for retailers and distributors. Its broad-spectrum antibacterial action, strong clinical relevance, and steady market demand make it a reliable product for growth in the critical care segment.